Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
LENSAR, Inc. LNSR
$2.48
+$0.03 (1.22%)
На 18:03, 12 мая 2023
Ранг: 3
Ключевые показатели
-
Marketcap
30556576.00000000
-
week52high
7.98
-
week52low
1.90
-
Revenue
35358000
-
P/E TTM
-1
-
Beta
-0.28645600
-
EPS
-1.88000000
-
Last Dividend
0.00000000
-
Next Earnings Date
08 мая 2023 г. в 12:30
Описание компании
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing a femtosecond laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism. Its LENSAR Laser System incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes, efficiency, and reproducibility by providing imaging, procedure planning, design, and precision. The company was incorporated in 2004 and is headquartered in Orlando, Florida.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| BTIG | Buy | 22 ноя 2021 г. | |
| SVB Leerink | Outperform | 24 февр 2021 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Connaughton Alan B. | A | 54356 | 54356 | 11 янв 2023 г. |
| Connaughton Alan B. | A | 281751 | 15530 | 11 янв 2023 г. |
| STAAB THOMAS R II | A | 23295 | 23295 | 11 янв 2023 г. |
| STAAB THOMAS R II | A | 141787 | 6656 | 11 янв 2023 г. |
| Wong Kendra | A | 16900 | 16900 | 11 янв 2023 г. |
| Wong Kendra | A | 20899 | 8490 | 11 янв 2023 г. |
| CURTIS NICHOLAS T | A | 77651 | 77651 | 11 янв 2023 г. |
| CURTIS NICHOLAS T | A | 793036 | 22186 | 11 янв 2023 г. |
| STAAB THOMAS R II | A | 135131 | 727 | 07 дек 2022 г. |
| STAAB THOMAS R II | A | 134404 | 2025 | 06 дек 2022 г. |
Новостная лента
LENSAR, Inc. (LNSR) Q3 2022 Earnings Call Transcript
Seeking Alpha
12 ноя 2022 г. в 11:29
LENSAR, Inc. (NASDAQ:LNSR ) Q3 2022 Results Conference Call November 9, 2022 8:30 AM ET Company Participants Lee Roth - Burns McClellan Nick Curtis - Chief Executive Officer Tom Staab - Chief Financial Officer Conference Call Participants Samuel Brodovsky - BTIG Operator Good morning, ladies and gentlemen. Thank you for standing by.
LENSAR, Inc. (LNSR) CEO Nicholas Curtis on Q2 2022 Results - Earnings Call Transcript
Seeking Alpha
08 авг 2022 г. в 10:59
LENSAR, Inc. (NASDAQ:LNSR ) Q2 2022 Earnings Conference Call August 8, 2022 8:30 AM ET Company Participants Lee Roth - Burns McClellan Nicholas Curtis - Chief Executive Officer Thomas Staab - Chief Financial Officer Conference Call Participants Ryan Zimmerman - BTIG Operator Good morning and thank you for your participation. At this time, all participants are in a listen-only mode.
LENSAR to Report Second Quarter 2022 Financial Results on Monday, August 8, 2022
Business Wire
01 авг 2022 г. в 08:00
ORLANDO, Fla.--(BUSINESS WIRE)--LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or “the Company”), a global medical technology company focused on advanced femtosecond laser surgical solutions for the treatment of cataracts, today announced that the Company's second quarter 2022 financial results will be released before market open on Monday, August 8, 2022. LENSAR's management will host a conference call and webcast at 8:30 am ET on Monday, August 8, 2022 to discuss the financial results and recent corpo
Why Lensar Shares Are Trading Higher Today
Benzinga
13 июн 2022 г. в 09:14
The FDA granted 510(k) clearance to Lensar Inc's (NASDAQ: LNSR) next-generation ALLY Adaptive Cataract Treatment System (ALLY System). ALLY is the first FDA-cleared platform to enable cataract surgeons to complete the femtosecond-laser-assisted cataract surgery (FLACS).
LENSAR, Inc. (LNSR) CEO Nick Curtis on Q1 2022 Results - Earnings Call Transcript
Seeking Alpha
09 мая 2022 г. в 10:57
LENSAR, Inc. (NASDAQ:LNSR ) Q1 2022 Earnings Conference Call May 9, 2022 8:30 AM ET Company Participants Cameron Radinovic - Burns McClellan Nick Curtis - Chief Executive Officer Tom Staab - Chief Financial Officer Conference Call Participants Ryan Zimmerman - BTIG Danielle Antalffy - SVB Operator Good morning, and thank you for your participation. At this time, all participants are in a listen-only mode.